Evidence was found that Smad-3 deficiency attenuates pulmonary fibrosis and that the inhibitor Smad-7 prevents the phosphorylation of Smad-2 and Smad-3, reducing the fibrotic phenomenon [75]. Here, SMAD3 is linked to pulmonary fibrosis.